Vestibular Migraine Clinical Trial
Official title:
The Role Of Vestibular Rehabilitation Therapy In Management Of Vestibular Migraine Patients
1. To assess the criteria of positional vertigo in vestibular migraine patients 2. To assess the effect of vestibular rehabilitation therapy in management of positional vertigo in vestibular migraine patients
Status | Not yet recruiting |
Enrollment | 30 |
Est. completion date | October 2024 |
Est. primary completion date | September 2024 |
Accepts healthy volunteers | |
Gender | All |
Age group | 20 Years to 50 Years |
Eligibility | Inclusion Criteria: - Age: from 20 years to 50 years old. - Sex: male or female. - Vestibular migraine Exclusion Criteria: 1. Evidence of neurological or psychiatric illness. 2. Patients with other types of headache. 3. Evidence of active middle ear disease. 4. History of head trauma, surgery or ototoxic drug therapy 5. Exclude other causes of vestibular disorder |
Country | Name | City | State |
---|---|---|---|
n/a |
Lead Sponsor | Collaborator |
---|---|
Assiut University |
Headache Classification Committee of the International Headache Society (IHS). The International Classification of Headache Disorders, 3rd edition (beta version). Cephalalgia. 2013 Jul;33(9):629-808. doi: 10.1177/0333102413485658. — View Citation
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | The Role Of Vestibular Rehabilitation Therapy In Management Of Vestibular Migraine Patients | quantify the effects of vestibular migrine some of them are as following dizzness handicap inventory | through study completion, an average of 1 year |
Status | Clinical Trial | Phase | |
---|---|---|---|
Enrolling by invitation |
NCT04196933 -
Analysis of Vestibular Compensation Following Clinical Intervention for Vestibular Schwannoma
|
N/A | |
Recruiting |
NCT04417361 -
Galcanezumab for Vestibular Migraine
|
Phase 2 | |
Enrolling by invitation |
NCT05396482 -
Assesment of Hearing in Patients With Vestibular Migra
|
||
Completed |
NCT03979677 -
Effects of Lifestyle Modification on Vestibular Migraine
|
N/A | |
Completed |
NCT05157399 -
Quantification of the Effect of the OtoBand on Objective Measures of Vertigo and Dizziness
|
N/A | |
Not yet recruiting |
NCT05914207 -
Non-Pharmacological Treatment of Vestibular Migraine in Children and Adolescent
|
N/A | |
Enrolling by invitation |
NCT06417684 -
Comparison of Amitriptyline to Lifestyle Modification as Intervention for Vestibular Migraine
|
Early Phase 1 | |
Recruiting |
NCT04939922 -
China Headache Registry Study
|
||
Recruiting |
NCT05472675 -
Local Sensory Nerve Block in the Treatment of Vestibular Migraine
|
N/A | |
Recruiting |
NCT05418218 -
International Headache Registry Study
|
||
Suspended |
NCT04026516 -
CAVA: Dizziness Trial
|
N/A | |
Withdrawn |
NCT03578354 -
4-Aminopyridine, Atenolol, or Placebo in Patients With Vestibular Migraine
|
Phase 2 | |
Completed |
NCT02350985 -
Comparison of Propranolol and Venlafaxine in Treatment of Vestibular Migraine
|
Phase 4 | |
Completed |
NCT03417596 -
Vestibular Rehabilitation in Patients With Vestibular Migraine
|
N/A | |
Not yet recruiting |
NCT04664088 -
Acupuncture for Prophylaxis of Vestibular Migraine
|
N/A | |
Enrolling by invitation |
NCT06267924 -
SENSE-VM: Safety and Effectiveness of a Novel Medical Device for Symptom Ease in Vestibular Migraines
|
N/A | |
Completed |
NCT05960786 -
Treating the Symptoms of Vertigo in a Real-world Setting Using the OtoBand
|
N/A | |
Completed |
NCT02447991 -
Rizatriptan for Episodic Dizziness in Vestibular Migraine
|
Phase 2/Phase 3 | |
Recruiting |
NCT04935970 -
Metabolic Disorders and Vertigo
|
||
Completed |
NCT01669304 -
Verapamil vs. Sertraline for Vestibular Migraine & Chronic Subjective Dizziness
|
Phase 1 |